Journal Logo

Articles by Z. Abbaszadeh

ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON-HODGKIN LYMPHOMA: S1635

Del Bufalo, F.; Merli, P.; Vinti, L.; More

HemaSphere. 3:755, June 2019.